Related Experiment Videos
Tolerance and physical dependence induced by dermorphin in rats
European Journal of Pharmacology
|March 26, 1985
Summary
Dermorphin, a potent analgesic peptide, induced dose-dependent tolerance and physical dependence in rats, mirroring morphine
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Dermorphin is a potent opioid peptide with significant analgesic properties.
- Understanding the long-term effects of dermorphin, including tolerance and dependence, is crucial for its therapeutic potential.
Purpose of the Study:
- To investigate the capacity of dermorphin to induce tolerance and physical dependence in a rat model.
- To characterize the withdrawal syndrome associated with dermorphin dependence.
Main Methods:
- Chronic intracerebroventricular infusion of dermorphin in rats using osmotic minipumps.
- Assessment of tolerance through reduced duration of analgesia, catalepsy, and rigidity.
- Induction of withdrawal syndrome using naloxone challenge to reveal physical dependence.
Main Results:
- Dermorphin administration led to dose-dependent tolerance, developing within 48 hours.
- Physical dependence was established after 3 days of continuous peptide infusion.
- Naloxone precipitated a withdrawal syndrome with symptoms including escape behavior, shaking, salivation, and rhinorrhea, similar to morphine withdrawal.
Conclusions:
- Dermorphin exhibits tolerance and physical dependence liabilities comparable to traditional opiates.
- The findings suggest that dermorphin shares key pharmacological characteristics with morphine regarding antinociception, tolerance, and dependence.